Stockreport

Tonix Trial Update, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF SummaryTonix announced it has reached 50% enrollment in its RELIEF trial.Sanofi's meningococcal vaccine is approved.Glaxo’s Dostarlimab shows positive data in Endometria [Read more]